1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

OB/GYN Coverage

Discussion in 'Watson' started by Anonymous, May 13, 2012 at 12:10 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I heard that the SAS team will start calling on more OB/GYNs. Has anyone else heard this to be true?
     

  2. Anonymous

    Anonymous Guest

    Are they pusshing the ring?
     
  3. anonymous

    anonymous Guest

    Anyone else doing the NIPT testing on the side, getting 40% commission. Missed the boat on pain/scar creams but know some reps killing it doing this on the side. Any experiences would be appreciated. Not sure whether to pursue or not